AVACTA
LIVE

Serial Number

87026844

Owner

Avacta Limited

Attorney

Christina M. Licursi

Filing Date

May 5, 2016

Add to watchlist:

No watchlists yet
View on USPTO

AVACTA Trademark

Serial Number: 87026844 • Registration: 5592806

AVACTA is a trademark filed by Avacta Limited on May 5, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Avacta Limited (7 trademarks)

Wetherby LS237FA , GB

Entity Type: 99

Trademark Details

Filing Date

May 5, 2016

Registration Date

October 30, 2018

Published for Opposition

August 14, 2018

Goods & Services

[ Reagents for use in veterinary and medical diagnostic tests; reagents for use in medical and veterinary screening; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of biological samples, particularly blood; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of samples, particularly blood; diagnostic preparations for use in relation to food intolerance testing; affinity reagents, including antibodies, and diagnostic kits consisting primarily of medical antibodies and reagents for medical and veterinary use for use in medical and veterinary screening for the detection of diseases, allergies, infections, disorders, and for immunity testing; antigens for medical diagnostic use and veterinary diagnostic use; pharmaceutical preparations containing antigens for use in medical and veterinary treatment; substrates impregnated with or carrying antigens for medical diagnostic use and veterinary diagnostic use; antibodies for medical diagnostic use and veterinary diagnostic use; diagnostic and/or pharmaceutical preparations containing antibodies for medical diagnostic use and veterinary diagnostic use; substrates impregnated with or carrying antibodies for medical diagnostic use and veterinary diagnostic use; wound dressings; medical plasters; antiseptic wipes; diagnostic kits consisting primarily of diagnostic reagents, affinity reagents, antibodies, antigens, wound dressings and/or antiseptic wipes for medical diagnostic use and veterinary diagnostic use; genetic identity tests comprised of reagents for medical purposes; genetic identity tests for animals comprised of reagents for medical purposes; in-vitro diagnostic tests for predicting gender; in-vitro ovulation prediction test kits for home use; food intolerance test kits comprising diagnostic test patches for application to the skin for determining allergies ]

Reagents for use in scientific research; reagents for use in scientific screening; [ genetic identity tests comprised of reagents for non-medical purposes; genetic identity tests for animals comprised of reagents for non-medical purposes; ] reagents for use in scientific, medical, [ and/or veterinary research; ] affinity reagents, including antibodies, [ and diagnostic kits ] consisting primarily of antibodies and reagents, all for use in scientific, medical, [ and/or veterinary ] research; chemical preparations containing antigens for use in scientific, medical, [ and/or veterinary ] research [; chemical preparations containing antigens for scientific diagnostic use; diagnostic and/or pharmaceutical preparations containing antibodies for scientific diagnostic use; substrates impregnated with or carrying antibodies for scientific diagnostic use; diagnostic kits consisting primarily of diagnostic reagents, affinity reagents, antibodies, antigens, wound dressings and/or antiseptic wipes for scientific diagnostic use; antibodies for scientific diagnostic use; diagnostic preparations containing antibodies for scientific diagnostic use; substrates impregnated with or carrying antibodies for scientific diagnostic use; diagnostic kits consisting primarily of diagnostic reagents, affinity reagents, antibodies, antigens, wound dressings and/or antiseptic wipes for scientific diagnostic use ]

[ Antibody medical screening services; food intolerance medical testing; allergy medical testing; medical infection testing; medical services for detecting or measuring factors indicative of health conditions or disorders; medical services for detecting or measuring selected antibodies in biological samples; antibody screening services; medical testing for diseases; providing medical information relating to the aforesaid services including by computer networks and/or the Internet; providing medical information, consultancy and advisory services relating to any of the aforesaid services; genetic testing services for medical diagnostic purposes; medical consultancy and advisory services in the fields of medical diagnostics, blood analysis and genetics ]

[ Medical laboratory apparatus for medical diagnosis for serological immunity and genetics, allergies, ectoparasites, fungal infections, bacterial or malassezia infections, ear infections, atopic dermatitis, anal gland disorders, asthma, equine recurrent airway obstruction, or insect bites hypersensitivity; diagnostic apparatus for medical and veterinary use, namely, serological immune-assays and genetic testing apparatus; genetic testing kits comprised of reagents and testing apparatus for medical purposes; genetic testing kits comprised of reagents and testing apparatus for medical purposes for animals; medical apparatus for identifying genetic status for use in the diagnosis of genetic diseases; medical apparatus for identifying genetic disease for medical use; apparatus for use in taking and/or collecting biological samples, particularly blood samples; apparatus for use in taking and/or collecting samples from animals, particularly blood samples; blood and tissue testing apparatus for use in assays of biological samples, particularly blood for the detection of proteins; blood and tissue testing apparatus for use in assays of blood and tissue samples from animals; lancets; blood collection devices, namely, glass slides, cups, bags, syringes, tubes, vials; absorbent devices for collecting blood, namely, sponges, polymer materials, gels and cloths; containers adapted for the disposal of medical instruments, syringes and other contaminated medical waste and containers adapted to contain sterile sponges, polymer materials, gels and cloths for collecting blood; medical apparatus for use in assays of veterinary samples, particularly blood; biological sample testing kits comprised of blood collection devices, namely, glass slides, cups, bags, syringes, tubes, vials, absorbent devices for collecting blood, namely, sponges, polymer materials, gels and cloths, and/or containers adapted for the disposal of medical instruments, syringes and other contaminated medical waste and containers adapted to contain sterile sponges, polymer materials, gels and cloths for collecting blood; blood collection kits comprised of blood collection bags, holders for medical sample tubes and vials, and medical sample tubes and vials; blood collection kits comprised of blood collection bags, holders for medical sample tubes and vials, and medical sample tubes and vials for use in relation to animals; test apparatus for carrying out diagnostic tests on human or animal blood and tissue for purposes relating to the health or wellbeing of humans and/or animals; apparatus for performing in vitro diagnostic tests, namely, lateral flow devices, dipstick tests, biosensors, immunoassay apparatus; analyzers for in-vitro medical diagnostic tests; blood taking and collection kits comprising lancets and blood collecting tubes; veterinary and medical sample testing kits comprised of blood collection devices, namely, glass slides, cups, bags, syringes, tubes, vials, absorbent devices for collecting blood, namely, sponges, polymer materials, gels and cloths, and/or containers adapted for the disposal of medical instruments, syringes and other contaminated medical waste and containers adapted to contain sterile sponges, polymer materials, gels and cloths for collecting blood, blood testing apparatus and materials, namely, blood collecting tubes and sampling sold in kit form for use in taking and/or testing veterinary and medical samples, particularly blood ]

Scientific services namely scientific laboratory services; scientific research and development services; laboratory research services and laboratory testing services [ in the field of medical diagnostics; ] laboratory research services and laboratory testing services all relating to the examination, analysis or assaying of biological samples [; laboratory research services and laboratory testing services, all relating to the examination, analysis or assaying of samples from animals; blood analysis; providing medical and scientific research information in the field of medical diagnostics, blood analysis and genetics including by computer networks and/or the Internet; preparation of reports relating to laboratory tests in the fields of medical diagnostics, blood analysis and genetics ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Aug 19, 2025 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Aug 19, 2025 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 11, 2025 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 29, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 29, 2025 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 29, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 29, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 29, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 29, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 29, 2025 COAR
TEAS SECTION 8 RECEIVED
Apr 29, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 30, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 30, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 14, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 14, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 25, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2018 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2018 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2018 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 23, 2018 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 20, 2018 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 4, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 3, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 3, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 6, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jul 6, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jul 6, 2017 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 4, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 2, 2017 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 18, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 6, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 6, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 6, 2016 CNRT
ASSIGNED TO EXAMINER
Aug 20, 2016 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jun 18, 2016 AMPX
ASSIGNED TO LIE
Jun 8, 2016 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
May 26, 2016 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2016 NWOS
NEW APPLICATION ENTERED
May 9, 2016 NWAP